Administration of silica sensitizes lipopolysaccharide responsiveness of murine macrophages but inhibits T and B cell priming by inhibition of antigen presenting function

Immunological Investigations

Volumn 27, Issue 3, 1998, Pages 181-199

  Rao, T Dharma ^a   Frey, Alan B ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; SILICON DIOXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM EXUDATE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0031806515     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820139809089455     Document Type: Article

References (29)

1. R. A. Ezekowitz. "Natural Immunity", Academic Press, (1989) 15-32.
2. J. Debrick, P. Campbell and U. Staerz. J. Immunol. 147, 2846-2851 (1991).
3. H. Udono, D. Levey and P. Srivastava. Proc. Natl. Acad. Sci. 91, 3077-3081 (1994).
4. C. R. Roland, L. Walp, R. M. Stack and M. W. Flye. J. Immunol. 153, 5453-5464 (1994).
5. J. Samsom, A. Annema, P. Groeneveld, N. v. Rooijen, J. Langermans and R. v. Furth. Infect. Immun. 65, 986-993 (1997).
6. M. Levy and E. Wheelock. J. Immunol. 115, 41-48 (1975).
7. R. Keller, J. Natl. Can. Inst. 57, 1355-1361 (1976).
8. E. Kagan and D. Hartmann. Meth. Enzymol. 108, 325-335 (1984).
9. U. Oschilewski, U. Kisel and H. Kolb. Diabetes. 34, 197-199 (1985).
10. B. Charlton, A. Bacelj and T. Mandel. Diabetes. 37, 930-935 (1988).
11. M. Oschilewski, E. Schwab, U. Kiesel, U. Opitz, K. Stunkel, V. Kolb-Bachofen and H. Kolb. Immunol. Letts. 12, 289-294 (1986).
12. C. Brosnan, M. Bornstein and B. Bloom. J. Immunol. 126, 614-620 (1981).
13. J. Y. Wu, B. H. Gardner, N. N. Kushner, L. A. Pozzi, C. R. Kensil, P. A. Cloutier, R. T. Couglin and M. J. Newman. Cell. Immunol. 154, 393-406 (1994).
14. R. Ciavarra, K. Buher, N. V. Rooijen and B. Tedeschi. J. Immunol. 158, 1749-1755 (1997).
15. S. Vogel, K. English and A. O'Brien. Infect. Immun. 38, 681-685 (1982).
16. P. C. Hanna, M. Acosta and R. J. Collier. Proc. Natl. Acad. Sci. 90, 10198-10201 (1993).
17. A. B. Frey and T. D. Rao. Inf. Imm. 63, 2596-2603 (1995).
18. T. D. Rao and A. B. Frey. Imm. Inf. Dis. 5, 27-39 (1995).
19. T. D. Rao and A. B. Frey. Cell. Immunol. 162, 225-234 (1995).
20. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach and W. Strober. (1992). Current Protocols in Immunology. 1,
21. L. Appleman and A. Frey. Int. J. Cancer. 63, 576-583 (1995).
22. C. Salkowski, R. Neta, T. Wynn, G. Straamann, N. v. Rooijen and S. Voget. J. Immunol. 155, 3168-3179 (1997).
23. N. v. Rooijen, N. Kors and G. Kraal. J. Leuk. Biol. 45, 97-104 (1989).
24. N. v. Rooijen and A. Sanders. J. Immunol. Meth. 174, 83-93 (1994).
25. N. v. Rooijen, O. Wijurg, G. v. d. Dobbelsteen and A. Sanders. Cur. Top. Microbiol. Immunol. 210, 159-165 (1996).
26. Q. Qian, M. Jutila, N. v. Rooijen and J. Cutler. J. Immunol. 152, 5000-5008 (1994).
27. T. K. Eisenstein. "Macrophage-pathogen interactions", Marcel Dekker, Inc., (1994) 203-224.
28. J. Albina and W. Henry. J. Surg. Res. 50, 403-409 (1991).
29. J. Albina, J. Abate and W. Henry. J. Immunol. 147, 144-151 (1991).